Internal Medicine, Infectious Disease · Lumberton, NC
NPI
1740234434
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
395 W 27th St
Lumberton, NC, 28358
Phone (910) 738-3434
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
1,484 services
Medicare patients, 2024
275
Average age 71
Drug cost, 2024
$1.7M
976 prescriptions
Company payments, 2025
$1,185
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Obiefuna P Okoye was code 99232 (hospital e&m - subsequent), 709 times for 192 patients. In total Obiefuna P Okoye billed 1,484 services in 11 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 709 | 192 | $57.44 | $41K |
| 99233 Hospital E&M - Subsequent | Facility | 338 | 187 | $86.18 | $29K |
| 99223 Hospital E&M - Initial | Facility | 251 | 207 | $124.52 | $31K |
| 99214 Office E&M - Established | Office | 93 | 54 | $83.96 | $7,808 |
| 99213 Office E&M - Established | Office | 37 | 29 | $64.44 | $2,384 |
| 99222 Hospital E&M - Initial | Facility | 25 | 25 | $95.09 | $2,377 |
| 99215 Office E&M - Established | Office | 11 | 11 | $131.99 | $1,452 |
By year: 2022 $206K for 2,712 services; 2023 $147K for 1,835 services; 2024 $117K for 1,484 services.
Medicare prescription drug claims, 2024
In 2024, the drug Obiefuna P Okoye prescribed most often to Medicare patients was Dovato (Dolutegravir Sodium/Lamivudine), with 157 prescriptions and refills. In total Obiefuna P Okoye wrote 976 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dovato Dolutegravir Sodium/Lamivudine | 157 | 157 | 21 | $493K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 143 | 143 | 17 | $578K |
| Doxycycline Hyclate Generic | 87 | 89 | 33 | $2,520 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 85 | 85 | 29 | $2,149 |
| Cephalexin Generic | 30 | 35 | Under 11 | $249 |
| Azithromycin Generic | 25 | 25 | Under 11 | $1,426 |
| Rifampin Generic | 25 | 25 | Under 11 | $1,724 |
| Prezcobix Darunavir/Cobicistat | 24 | 24 | Under 11 | $58K |
| Tivicay Dolutegravir Sodium | 23 | 23 | Under 11 | $51K |
| Cefdinir Generic | 21 | 21 | Under 11 | $569 |
| Nystatin Generic | 20 | 20 | Under 11 | $357 |
| Ethambutol Hcl Generic | 20 | 20 | Under 11 | $1,670 |
| Cefazolin Sodium Generic | 18 | 18 | Under 11 | $931 |
| Juluca Dolutegravir/Rilpivirine | 17 | 17 | Under 11 | $59K |
| Methenamine Hippurate Generic | 15 | 15 | Under 11 | $153 |
Brand drugs: 455 claims; generic drugs: 521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Obiefuna P Okoye $1,185 ($1,185 in general payments such as food, travel and fees) from 8 companies. The largest payer was ViiV Healthcare Company with $331.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.